Long-term outcomes of autologous skeletal myoblast cell-sheet transplantation for end-stage ischemic cardiomyopathy

[1]  A. Hirayama,et al.  Restrictive mitral annuloplasty with or without coronary artery bypass grafting in ischemic mitral regurgitation , 2020, ESC heart failure.

[2]  Darcy L. DiFede,et al.  Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy , 2019, EBioMedicine.

[3]  L. Anderson,et al.  Impaired renal function affects clinical outcomes and management of patients with heart failure , 2017, ESC heart failure.

[4]  S. Hamada,et al.  Phase I Clinical Trial of Autologous Stem Cell–Sheet Transplantation Therapy for Treating Cardiomyopathy , 2017, Journal of the American Heart Association.

[5]  M. Isobe,et al.  Registry Report on Heart Transplantation in Japan (June 2016). , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[6]  M. Acker,et al.  Dealing with surgical left ventricular assist device complications. , 2015, Journal of thoracic disease.

[7]  D. Berman,et al.  Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. , 2015, JACC. Cardiovascular imaging.

[8]  Minoru Ono,et al.  Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[9]  T. Watabe,et al.  Cell-sheet therapy with omentopexy promotes arteriogenesis and improves coronary circulation physiology in failing heart , 2020 .

[10]  Minoru Ono,et al.  The registry report of heart transplantation in Japan (1999-2013). , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[11]  Peter Libby,et al.  Cardiovascular remodelling in coronary artery disease and heart failure , 2014, The Lancet.

[12]  K. Taniguchi,et al.  Restrictive mitral annuloplasty with or without surgical ventricular reconstruction in ischaemic cardiomyopathy: impacts on neurohormonal activation, reverse left ventricular remodelling and survival , 2014, European journal of heart failure.

[13]  Y. Sawa,et al.  The use of cell-sheet technique eliminates arrhythmogenicity of skeletal myoblast-based therapy to the heart with enhanced therapeutic effects. , 2013, International journal of cardiology.

[14]  T. Okano,et al.  Enhanced Survival of Transplanted Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes by the Combination of Cell Sheets With the Pedicled Omental Flap Technique in a Porcine Heart , 2013, Circulation.

[15]  M. Ohishi,et al.  Mitral Valve Repair for Medically Refractory Functional Mitral Regurgitation in Patients With End-Stage Renal Disease and Advanced Heart Failure , 2012 .

[16]  Takashi Daimon,et al.  Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.

[17]  T. Okano,et al.  Myoblast Sheet Can Prevent the Impairment of Cardiac Diastolic Function and Late Remodeling After Left Ventricular Restoration in Ischemic Cardiomyopathy , 2012, Transplantation.

[18]  T. Okano,et al.  Addition of mesenchymal stem cells enhances the therapeutic effects of skeletal myoblast cell-sheet transplantation in a rat ischemic cardiomyopathy model. , 2014, Tissue engineering. Part A.

[19]  M. Nishino,et al.  Does Stringent Restrictive Annuloplasty for Functional Mitral Regurgitation Cause Functional Mitral Stenosis and Pulmonary Hypertension? , 2011, Circulation.

[20]  Ajay M Shah,et al.  In search of new therapeutic targets and strategies for heart failure: recent advances in basic science , 2011, The Lancet.

[21]  D. Berman,et al.  Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.

[22]  Teruo Okano,et al.  Impaired Myocardium Regeneration With Skeletal Cell Sheets—A Preclinical Trial for Tissue-Engineered Regeneration Therapy , 2010, Transplantation.

[23]  P. Pibarot,et al.  Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. , 2010, Journal of the American College of Cardiology.

[24]  P. Ponikowski,et al.  Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative , 2009, European heart journal.

[25]  Teruo Okano,et al.  Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart. , 2009, The Journal of thoracic and cardiovascular surgery.

[26]  Jeroen J. Bax,et al.  Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction , 2009, Heart.

[27]  C. Visser,et al.  Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. , 2008, European heart journal.

[28]  O. Alfieri,et al.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.

[29]  D. Mozaffarian,et al.  The Seattle Heart Failure Model: Prediction of Survival in Heart Failure , 2006, Circulation.

[30]  G. Buckberg,et al.  Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. , 2004, Journal of the American College of Cardiology.

[31]  Satoko Nakamura,et al.  Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  Mitsuo Umezu,et al.  Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces , 2002, Circulation research.

[33]  Salim Yusuf,et al.  The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. , 2002, Journal of the American College of Cardiology.

[34]  J J Bax,et al.  Time Course of Functional Recovery of Stunned and Hibernating Segments After Surgical Revascularization , 2001, Circulation.

[35]  Jeroen J. Bax,et al.  Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. , 1997, Journal of the American College of Cardiology.

[36]  W. Schaper,et al.  Hibernating myocardium: an incomplete adaptation to ischemia. , 1997, Circulation.

[37]  H. White,et al.  End‐Systolic Volume and Long‐term Survival After Coronary Artery Bypass Graft Surgery in Patients With Impaired Left Ventricular Function , 1994, Circulation.

[38]  H. Matsuda,et al.  Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. , 1990, Circulation.

[39]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[40]  M. Isobe,et al.  The Registry Report of Heart Transplantation in Japan (1999-2014). , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[41]  川村 匡,et al.  Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model , 2013 .